SenzoHealth

Developing high accuracy diagnostics.

[SenzoHealth @SenzoHealth]

The headline is clear; we need better rapid self-tests for existing pandemics like Tuberculosis, and future pandemics we are yet to encounter. At Senzo we are building the high-accuracy diagnostics today that we will urgently need tomorrow.

Full study: https://t.co/S0qax5tyVn

[SenzoHealth @SenzoHealth]

𝗧𝗵𝗶𝘀 𝗶𝘀 𝘄𝗵𝘆 𝘄𝗲 𝗮𝗿𝗲 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗶𝗻𝗴 𝗣𝗖𝗥-𝗮𝗰𝗰𝘂𝗿𝗮𝘁𝗲 𝗹𝗮𝘁𝗲𝗿𝗮𝗹 𝗳𝗹𝗼𝘄 𝗱𝗲𝘃𝗶𝘀𝗲 𝘁𝗲𝘀𝘁𝘀. A new study by @TheLancet puts Lateral Flow Devise sensitivity for alpha, delta, and omicron Covid waves at just 63·2%.

[SenzoHealth @SenzoHealth]

https://t.co/btjnv7Xn34

[SenzoHealth @SenzoHealth]

𝗧𝗵𝗲 𝗲𝗮𝗿𝗹𝗶𝗲𝗿 𝘄𝗲 𝗰𝗮𝗻 𝗱𝗲𝘁𝗲𝗰𝘁, 𝘁𝗵𝗲 𝗲𝗮𝗿𝗹𝗶𝗲𝗿 𝘄𝗲 𝗰𝗮𝗻 𝘁𝗿𝗲𝗮𝘁, 𝘁𝗵𝗲 𝗲𝗮𝗿𝗹𝗶𝗲𝗿 𝘄𝗲 𝗰𝗮𝗻 𝗰𝘂𝗿𝗲. https://t.co/btjnv7Xn34

[SenzoHealth @SenzoHealth]

Whilst most articles currently focus on how AI will replace your job, we're interested in how AI will diagnose your cancer, virus, infection, and illness.

[SenzoHealth @SenzoHealth]

#ageingpopulation #globalchallenge #healthcare #futurerequirements #demographicchange #elderlycare #populationgrowth #agingdemographic

[SenzoHealth @SenzoHealth]

𝗗𝗲𝘀𝗶𝗴𝗻 𝘁𝗼𝗱𝗮𝘆 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝗺𝗲𝗻𝘁𝘀 𝗼𝗳 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄. By 2025, 11% of the global population, and 21% of the European population, will be over 65 years old. This ageing demographic will increase the demand for healthcare.

[SenzoHealth @SenzoHealth]

Simple, accurate and affordable diagnostics, which can be tuned to a range of targets, providing both reliable testing and rolling surveillance will provide a valuable solution for future requirements.

[SenzoHealth @SenzoHealth]

Announcement: 𝗦𝗲𝗻𝘇𝗼 𝗮𝗻𝗱 𝗔𝗯𝗶𝗻𝗴𝗱𝗼𝗻 𝗛𝗲𝗮𝗹𝘁𝗵 𝗘𝗻𝘁𝗲𝗿 𝗜𝗻𝘁𝗼 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽. Abingdon Health's CDMO service to support Senzo in leveraging its innovative, high-accuracy Amplified Lateral Flow (ALF) platform. https://t.co/oXS7lDEJsd

[SenzoHealth @SenzoHealth]

Detailed analysis of the study in @CNN and @WSJ articles below:

#ProstateCancer #Surveillance #ActiveMonitoring #Testing #MedicalResearch #MensHealth

https://t.co/lHDoF4n7Lv

https://t.co/ib5Li8oJs5.

[SenzoHealth @SenzoHealth]

For the 11% of US men who will be diagnosed with prostate cancer, a new study shows surveillance and active monitoring is often the best approach for non-aggressive cancers.

From monitoring to diagnosing, the better our testing, the better our decisions.

[SenzoHealth @SenzoHealth]

𝟭/𝟯𝗿𝗱 𝗼𝗳 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱'𝘀 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗶𝗻𝗳𝗲𝗰𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 𝗧𝘂𝗯𝗲𝗿𝗰𝘂𝗹𝗼𝘀𝗶𝘀. Here are 3 of the most important organisations currently working to bring an end to this pandemic;

@WHO @USAID @GlobalFund

[SenzoHealth @SenzoHealth]

To learn more about how Senzo is working to create better diagnostics to help end the current TB pandemic please get in touch.

#EndTBTogether #TBTreatment #TBInfectionRates #DiagnosticsMatter #WHO #TBGlobalElimination

Source: https://t.co/QC7ghtR5OW

[SenzoHealth @SenzoHealth]

𝗧𝘂𝗯𝗲𝗿𝗰𝘂𝗹𝗼𝘀𝗶𝘀 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻 𝗿𝗮𝘁𝗲𝘀 𝗯𝘆 𝗰𝗼𝘂𝗻𝘁𝗿𝘆 (𝗪𝗛𝗢, 𝟭-𝟭𝟬).

In 2014, the WHO endorsed the End TB Strategy to eradicate tuberculosis globally by 2035.

[SenzoHealth @SenzoHealth]

This strategy committed to decreasing the number of people afflicted with TB by 90%, reducing TB-related deaths by 95%, and protecting families from the adverse effects of the disease. Whilst lots has been achieved, much remains to be done.

[SenzoHealth @SenzoHealth]

The faster we can diagnose, the faster we can treat. Learn more about our work at https://t.co/MvChlOZOTq.

[SenzoHealth @SenzoHealth]

At Senzo we are working to accelerate the home healthcare movement by developing and deploying fast, simple, accurate and affordable tests that anybody can use for a range of illnesses and diseases.

#healthcarerevolution #remotemedicine #hometesting

https://t.co/CuX8sGIUJS

[SenzoHealth @SenzoHealth]

According to @Bloomberg , Apple is making real progress in adding continuous glucose monitoring to the Apple Watch - the potential here is huge with 1 in 10 Americans having diabetes and using intermittent skin pricks to monitor glucose levels.

https://t.co/DvcXKouTuR

[SenzoHealth @SenzoHealth]

https://t.co/ha7Xi82QDb](https://t.co/ha7Xi82QDb

[SenzoHealth @SenzoHealth]

With the development of new multiplex tests, detecting flu, COVID-19, and RSV in a single diagnostic is becoming fast, affordable, and simple. These tests will become a staple of at-home healthcare better-tuning illness to treatment. #healthcare #diagnostics #innovation